Salivary markers quantification of oxidative stress in patients with periodontitis, before and after intensive periodontal treatment: a one-blinded, randomized, clinical trial

I. Converti; A. Palermo; A. Mancini; M.E. Maggiore; G.M. Tartaglia; E. Ferrara; F. Lorusso; A. Scarano; I.R. Bordea; C. Sforza; C. Maspero; M. Farronato; M.G. Cagetti; A. Patano; S. Ceci; A. Corriero; D. Hazballa; A. Gnoni; E. Gentile; A. Semjonova; K. Ferati; A. Bexheti-Ferati; M.F. Coscia; R. Del Prete; E. Xhajanka; AT. Pustina-Krasniqi; G. Malcangi

doi:10.23812/j.biol.regul.homeost.agents.202236.2S3.15

Publication Frequency

Quarterly since 2025

Journal Articles

Search scope

Journal Center

Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.

more

Volume Arrangement

2025

Vol 39, No 3 (2025)

Vol 39, No 2 (2025)

Vol 39, No 1 (2025)

Featured Articles

Macrophages in the pathogenesis of psoriasis and anti-psoriatic nanotherapies

Psoriasis is a common, chronic, and inflammatory skin disease. Macrophages account for about 61.3% of the inflammatory cells infiltrating psoriatic lesions. Modulating macrophage polarization, inhibiting their infiltration, and targeting the secretion of inflammatory factors and associated inflammatory pathways by these cells can alleviate psoriasis symptoms and inflammation. Moreover, nanomaterials as novel drug carriers, offer unique advantages such as large surface area, easy modification, high biocompatibility, good biodegradability, enhanced systemic adsorption, etc. Nanomaterials have great potential for efficient drug delivery and release, as well as improving therapeutic efficacy while reducing adverse effects. By systematically addressing the role of macrophages in psoriasis pathogenesis and the potential of nanomaterials in treating psoriasis through modulating macrophages, this review enhances our understanding of the disease mechanism and holds promise for novel therapeutic breakthroughs and advancements in the future treatment of psoriasis.

Salivary markers quantification of oxidative stress in patients with periodontitis, before and after intensive periodontal treatment: a one-blinded, randomized, clinical trial

I. Converti, A. Palermo, A. Mancini, M.E. Maggiore, G.M. Tartaglia, E. Ferrara, F. Lorusso, A. Scarano, I.R. Bordea, C. Sforza, C. Maspero, M. Farronato, M.G. Cagetti, A. Patano, S. Ceci, A. Corriero, D. Hazballa, A. Gnoni, E. Gentile, A. Semjonova, K. Ferati, A. Bexheti-Ferati, M.F. Coscia, R. Del Prete, E. Xhajanka, AT. Pustina-Krasniqi, G. Malcangi

Article ID: 6276
Vol 36, Issue 2S3, 2022

DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.202236.2S3.15

Received: 9 May 2022; Accepted: 9 May 2022; Available online: 9 May 2022; Issue release: 9 May 2022

Abstract

AIM: Periodontitis is one of the most common inflammatory and infectious diseases, significantly associatedwith circulating levels of oxidative stress biomarkers. A network of interacting molecular pathways comprisingproinflammatory mediators and reactive oxygen species (ROS) are involved in the progression of periodontitis. Theaim of the trial was to determine the effects of intensive periodontal treatment on the salivary levels of oxidativestress in patients with moderate periodontitis.MATERIALS AND METHODS: A randomized, one-blinded, controlled clinical trial was conducted with 3months of follow-up. A total of 58 patients were included in the study and randomized to receive intensive periodontaltreatment (Group Test) or conventional adult prophylaxis (Group Control). Salivary samples for determination oftotal antioxidant status (TAS), total oxidant status (TOS), nitric oxide (NO), myeloperoxidase (MPO), glutathione(GSH), malondialdehyde (MDA) levels, and 8-hydroxy-2’deoxyguanosine (X8-OHdG) concentrations werecollected from each patient prior to the periodontal treatment and at 3 months after the therapy.RESULTS: A significantly decreased NO, and MDA levels were registered in the Test Group compared to theControl Group (p<.0001), and the concentration of GSH was found to be significantly increased in the test groupcompared to the control group.CONCLUSION: Intensive periodontal treatment mitigates salivary oxidative stress in patients with moderateperiodontitis.

Keywords

periodontitis;oxidative stress;salivary markers;prophylaxis;periodontal treatment

References

Supporting Agencies

Copyright (c) 2022 I. Converti, A. Palermo, A. Mancini, M.E. Maggiore, G.M. Tartaglia, E. Ferrara, F. Lorusso, A. Scarano, I.R. Bordea, C. Sforza, C. Maspero, M. Farronato, M.G. Cagetti, A. Patano, S. Ceci, A. Corriero, D. Hazballa, A. Gnoni, E. Gentile, A. Semjonova, K. Ferati, A. Bexheti-Ferati, M.F. Coscia, R. Del Prete, E. Xhajanka, AT. Pustina-Krasniqi, G. Malcangi

This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Editor-in-Chief

Dr. Fabio Malavasi

Medical Genetics, University of Torino Medical School, Italy

Co-Editor-in-Chief

Prof. Marcello Iriti

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy

Indexing & Archiving

News & Announcements

2025-02-01

Notice of Change in Publication Schedule

In addition to the first issue that has already been published by the original publisher, there will be four more issues released this year, with scheduled publication dates in March, June, September, and December respectively.

2025-01-21

Notice: Ownership Transfer of the Journal

Starting from Volume 39 Issue 2 (2025), the ownership of Journal of Biological Regulators and Homeostatic Agents (ISSN: 0393-974X (P); 1724-6083 (O)) will be transferred from Biolife Sas to Asia Pacific Academy of Science Pte. Ltd. As of 21 January 2025, authors should make submissions to the new journal system and follow the author guidelines. Asia Pacific Academy of Science Pte. Ltd. will take over the publication of manuscripts being processed.

More Announcements...